-
Five years of legal cannabis: fewer charges, many hospitalizations and more than a few questions
Medical Mythbusting Commentary for October 11, 2023 Source:5 years of legal cannabis: fewer charges, many hospitalizations and more than a few questions Reference:Changes in Cannabis-Attributable Hospitalizations Following Nonmedical Cannabis Legalization in Canada
-
Researchers say modified version of CBD could help reverse fentanyl effects noted in in vitro trials. Much to be done to determine if it will progress to animal models and eventually testing in human trials.
Medical Mythbusting Commentary for July 21, 2023 Source:Researchers say modified version of CBD could help reverse fentanyl effects Reference:Structure–Activity Relationship Study of Cannabidiol-Based Analogs as Negative Allosteric Modulators of the μ-Opioid Receptor
-
Cancer warning labels will go on alcohol bottles in Ireland — a world first. It may reduce consumption for some and will be interested to see if it follows similar outcomes observed with cigarette warning labels.
Medical Mythbusting Commentary for May 23, 2023 Source:Cancer warning labels will go on alcohol bottles in Ireland — a world first
-
Study shows menthol flavour especially harmful to vape users. How a smoking-cessation product originally intended for harm reduction has been tainted by marketing and now increases the risk of harm among those who never smoked but have taken up vaping.
Medical Mythbusting Commentary for April 12, 2023 Source:Study shows menthol flavour especially harmful to vape users Reference:Electronic cigarette menthol flavoring is associated with increased inhaled micro and sub-micron particles and worse lung function in combustion cigarette smokers
-
Orexin-blocking medications to be investigated as potential treatment for drug addiction
Medical Mythbusting Commentary for November 11, 2022 Source:To Fight Addiction, Insomnia Drugs Could Block Orexin Reference:Orexin Reserve: A Mechanistic Framework for the Role of Orexins (Hypocretins) in Addiction
-
Observational design, limited study duration of three months use, variable dosing, self reporting bias, lack of feedback from family/friends about subject’s cannabis use limit conclusion that they are no more likely to lack motivation than non-users.
Medical Mythbusting Commentary for September 2, 2022 Source:Cannabis users no more likely to lack motivation than non-users: Study breaks ‘stoner’ stereotype Reference:Anhedonia, apathy, pleasure, and effort-based decision-making in adult and adolescent cannabis users and controls
-
Regulatory bodies in the EU and US imposing strict regulations and bans on heated tobacco-containing products and nicotine vaping products from Juul Labs respectively.
Medical Mythbusting Commentary for June 30, 2022 Source:EU proposes ban on flavoured heated tobacco productsFDA orders Juul Labs to remove products from US market
-
Small study of young people with no history of smoking or vaping showed single vaping session led to cellular oxidative stress responses (cause of inflammatory disease, heart disease, etc). More investigation needed to determine long-term use outcomes.
Medical Mythbusting Commentary for August 12, 2021 Source:‘Concerning’ study highlights dangers of vaping Reference:Association of 1 Vaping Session With Cellular Oxidative Stress in Otherwise Healthy Young People With No History of Smoking or Vaping
-
Philip Morris CEO states that cigarette sales to end in UK within 10 years and will be replaced with a harm-reduction IQOS (Tobacco Heating System) product approved by the FDA
Medical Mythbusting Commentary for July 29, 2021 Source: Tobacco CEO sees end to cigarettes in Britain in 10 years Reference: Tobacco Heating System (IQOS) Briefing Document presented to FDAFDA Authorizes Marketing of IQOS Tobacco Heating System with ‘Reduced Exposure’ Information